Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
25.80
-0.05 (-0.19%)
Streaming Delayed Price
Updated: 3:25 PM EDT, Aug 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023
December 26, 2022
Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results.
Via
The Motley Fool
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
December 23, 2022
Via
Benzinga
Why Did Viking Therapeutics Stock Skyrocket
December 21, 2022
VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.
Via
MarketBeat
12 Health Care Stocks Moving In Monday's Intraday Session
December 19, 2022
Via
Benzinga
Recap: Viking Therapeutics Q3 Earnings
October 26, 2022
Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Recap: Viking Therapeutics Q2 Earnings
July 27, 2022
Viking Therapeutics (NASDAQ:VKTX) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
FDA Lifts Clinical Hold On Viking Therapeutics' Rare Metabolic Disorder Study
July 19, 2022
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Is Elon Musk Stepping Down as Head of Twitter?
December 19, 2022
Elon Musk is in the news Monday after the billionaire held a poll asking if he should step down as head of social media company Twitter.
Via
InvestorPlace
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
December 19, 2022
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Is Cosmos Health (COSM) Stock Down 58% Today?
December 19, 2022
Cosmos Health (COSM) stock is falling hard on Monday after the healthcare company's shares underwent a major rally on Friday!
Via
InvestorPlace
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning
December 19, 2022
Good news can come in different forms.
Via
The Motley Fool
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today?
December 19, 2022
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.
Via
InvestorPlace
US Stocks Slightly Lower; Nasdaq Down 100 Points
December 19, 2022
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday.
Via
Benzinga
Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today
December 19, 2022
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
Via
Benzinga
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Biotech stocks are set to shine in 2023.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 16, 2022
Via
Benzinga
Earnings Outlook For Viking Therapeutics
October 25, 2022
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 11, 2022
Gainers
Via
Benzinga
Earnings Scheduled For October 26, 2022
October 26, 2022
Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion.
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For July 27, 2022
July 27, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Via
Benzinga
Viking Therapeutics Earnings Preview
July 26, 2022
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Viking...
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
July 19, 2022
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...
Via
Benzinga
U.S. FDA Lifts Clinical Hold On Viking Therapeutics' Initial-Stage Genetic Disorder Study
July 19, 2022
Viking Therapeutics (NASDAQ: VKTX) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the clinical trial of VK0214 in patients with X-linked...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 08, 2022
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 14, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 13, 2022
During Monday's trading, 1214 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.